Spire Wealth Management lessened its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...
Zacks.com on MSN1d
Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key MetricsIn its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.55 per share, reflecting a decline of 14.1% compared to the same period last ...
The stock's rise snapped a three-day losing streak.
Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Matthew Edwards joined Brown Rudnick as a transactions partner in its global life sciences practice group in London, the firm ...
U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...
NewsVoir New Delhi [India] 3 Indraprastha Apollo Hospitals proudly announces the launch of its Heart Valve Clinic a dedicated ...
Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been given a consensus rating of “Hold” by the twenty-six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback